We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$260B
AUM Growth
+$123M
Cap. Flow
-$889M
Cap. Flow %
-0.34%
Top 10 Hldgs %
14.45%
Holding
8,655
New
737
Increased
4,060
Reduced
2,893
Closed
594

Sector Composition

Rank Sector Weight
1 Technology 9.47%
2 Financials 6.72%
3 Healthcare 6.27%
4 Consumer Discretionary 5.76%
5 Industrials 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USX
5876
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$81K ﹤0.01%
16,906
+12,743
+306% +$58K
SCID
5877
DELISTED
Global X Scientific Beta Europe ETF
SCID
$81K ﹤0.01%
3,363
+231
+7% +$5.49K
BGG
5878
DELISTED
Briggs & Stratton Corp.
BGG
$81K ﹤0.01%
13,456
-40,748
-75% -$301K
EWUS icon
5879
iShares MSCI United Kingdom Small-Cap ETF
EWUS
$43M
$80K ﹤0.01%
2,123
+725
+52% +$26.6K
FSLY icon
5880
Fastly Inc
FSLY
$4.07B
$80K ﹤0.01%
3,330
-230
-6% -$5.42K
KNSA icon
5881
Kiniksa Pharmaceuticals
KNSA
$6.09B
$80K ﹤0.01%
9,364
+7,629
+440% +$84.3K
PYZ icon
5882
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$76.7M
$80K ﹤0.01%
1,383
-1,135
-45% -$66K
QEMM icon
5883
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$55.7M
$80K ﹤0.01%
1,390
-659
-32% -$37.8K
RMNI icon
5884
Rimini Street
RMNI
$447M
$80K ﹤0.01%
18,302
+11,523
+170% +$56.1K
TYD icon
5885
Direxion Daily 7-10 Year Treasury Bull 3X ETF
TYD
$32.2M
$80K ﹤0.01%
1,488
+1,366
+1,120% +$72.5K
WRLD icon
5886
World Acceptance Corp
WRLD
$897M
$80K ﹤0.01%
625
-969
-61% -$137K
EVLO
5887
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$80K ﹤0.01%
653
+470
+257% +$64.6K
HEWL
5888
DELISTED
iShares Currency Hedged MSCI Switzerland ETF
HEWL
$80K ﹤0.01%
2,670
-8
-0.3% -$233
CHK.PRD
5889
DELISTED
Chesapeake Energy Corp. 4.5% Cum. Cnvrtbl. Prfrd. Stock
CHK.PRD
$80K ﹤0.01%
1,851
-589
-24% -$26K
WBIB
5890
DELISTED
WBI BullBear Value 2000 ETF
WBIB
$80K ﹤0.01%
3,610
+1,773
+97% +$39.6K
OCUL icon
5891
Ocular Therapeutix
OCUL
$1.87B
$79K ﹤0.01%
25,883
+25,383
+5,077% +$113K
STRO icon
5892
Sutro Biopharma
STRO
$416M
$79K ﹤0.01%
869
+672
+341% +$67.9K
TSLF
5893
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$79K ﹤0.01%
5,219
+1,434
+38% +$21.4K
PAAS icon
5894
PUT
Pan American Silver
PAAS
$20.3B
$78K ﹤0.01%
5,000
-100
-2% -$1.62K
USMC icon
5895
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.68B
$78K ﹤0.01%
2,662
+2,135
+405% +$62.2K
HARP
5896
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$78K ﹤0.01%
569
+463
+437% +$65.1K
INDT
5897
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$78K ﹤0.01%
2,067
+565
+38% +$20.8K
RUBY
5898
DELISTED
Rubius Therapeutics, Inc
RUBY
$78K ﹤0.01%
+9,961
New +$116K
DBS
5899
DELISTED
Invesco DB Silver Fund
DBS
$78K ﹤0.01%
3,148
-362
-10% -$9K
GCAP
5900
DELISTED
Gain Capital Holdings, Inc.
GCAP
$78K ﹤0.01%
14,853
+14,832
+70,629% +$69.3K

Similar funds

UBS Group's Q3 2019 Portfolio in Review

As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2019 filing shows 737 new, 4,060 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
  • UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
  • UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
  • UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
  • UBS Group opened 737 new positions and closed 594 in Q3 2019.
  • UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.